Omer Iqbal has an M.D. degree and is a Research Associate Professor in the Hemostasis Research Laboratories in the Departments of Pathology and Ophthalmology at Loyola University Medical Center in Maywood, Ill, USA. He is an elected Fellow in the American College of Cardiology and European Society of Cardiology. For nearly two decades he has been actively involved in research in the fields of hemostasis and thrombosis. His scientific interests are very wide and varied including interventional cardiology, air travel thrombosis, personalized medicine, pharmacogenomics, pharmacogenetics, microarray technology and nanotechnology, cancer-associated hypercoagulable states, new anticoagulant, antiplatelet, and thrombolytic drugs. He is currently working on the molecular mechanism of action and point-of-care monitoring of new oral and intravenous antithrombin, anti-Xa anticoagulant drugs, glycoprotein IIb/IIIa receptor antagonists and thrombolytic agents. He is a member of numerous national and international scientific organizations including ACC, ESC, ISTH, IUA, ASH, and ASCO. He is an invited speaker at several national and international meetings. He has authored and coauthored a little over 100 publications.
Biography Updated on 11 June 2009